Pharma Journalist - Page 819 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Celgene Corporation asserted OTEZLA’s Phase II Clinical Trial data

Arterys sought FDA clearance for Oncology AI suite

Viz.ai sought De Novo FDA clearance for LVO strokes in CTA imaging

DreaMed Diabetics attained CE Mark for Platform tackling Type 1 diabetes

Evofem Biosciences completes enrollment in Phase 3 Clinical Trial for Amphora

Citius enrolls first patient in Mino-Lok Phase 3 Clinical trial

Eisai asserts positive results of Phase 3 Study for lenvatinib mesylate

Merck KGaA and Pfizer assert Phase III JAVELIN Lung 200 trial results

Tusker Medical enlists first patient for OTTER Study

Intralytix sought FDA clearance to begin Phase I/IIa Clinical Trials for bacteriophages